Clinical Study of Oral cMET Inhibitor INC280 in Adult Patients With Advanced Non-small Cell Lung Cancer Who Have Received One or Two Prior Lines of Therapy
Study Number: 

PH 271315

Phase: 
II
Trial categories: 
Lung
Non-Small Cell Lung Cancer (NSCLC)
Principal Investigator: